Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 22, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates ,...

Related Keywords

San Diego ,California ,United States ,Geoffrey Grande ,Navjot Rai ,Prnewswire Avidity Biosciences Inc ,Avidity Biosciences Inc ,Nasdaq ,Linkedin ,Antibody Oligonucleotide Conjugates ,Human Capital Management Committee ,Avidity Biosciences ,Inducement Incentive Award Plan ,Nasdaq Listing Rule ,Nasdaq Global Market ,Oligonucleotide Conjugates ,Markets ,